Skip to main content

Advertisement

SpringerLink
Log in

Effect of intravenous zoledronic acid infusion on electrocardiographic parameters in patients with osteoporosis

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

We evaluated the effects of zoledronic acid (ZA) therapy on electrocardiographic (ECG) parameters for the first time in the literature. Measurements were performed on ECGs obtained before and after ZA infusion on the same day as well as 1 month after the infusion. ZA infusion did not have any short- or long-term effect on any parameter that might be associated with the tendency for atrial fibrillation or ventricular arrhythmias.

Introduction

The aim of the present study was to evaluate the early and late effects of ZA therapy on ECG parameters which might be associated with the tendency for atrial and ventricular arrhythmias.

Methods

Consecutive patients with osteoporosis who were admitted to our clinic between December 2013 and December 2014 and who were scheduled to receive ZA infusion constituted our study population. Twelve-lead surface ECGs were obtained from all patients before and after ZA infusion on the same day as well as 1 month after the infusion. All ECG parameters were measured and compared with each other for each patient.

Results

Data of 100 patients were used in the analysis (9 male; 70.5 ± 11.6 years of age). There were no significant differences between repeated measurements regarding pmax, pmin, and p dispersion values. QT max and QT min values were significantly increased after infusion; however, there were no significant changes in QT dispersion, Tp-e interval, and Tp-e dispersion values.

Conclusions

ZA infusion did not affect P wave dispersion both at the immediate post-infusion period and 1 month after infusion. QT values were significantly increased early after ZA infusion; however, there were no significant differences in parameters reflecting disparity of ventricular recovery times and transmural dispersion of ventricular repolarization. Based on these observations, it may be suggested that ZA infusion did not have any short- or long-term effect on any parameter that might be associated with the tendency for atrial fibrillation or ventricular arrhythmias.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dalle Carbonare L, Zannatta M, Gasparetto A, Valenti MT (2010) Safety and tolerability of zoledronic acid and other biphosphonates in osteoporosis management. Drug Healtc Patient Saf 2:121–137

    Article  CAS  Google Scholar 

  2. Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, et al. (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809–1822

    Article  CAS  PubMed  Google Scholar 

  3. Pazianas M, Compston J, Huang CL (2010) Atrial fibrillation and biphosphonate therapy. J Bone Miner Res 25:2–10

    Article  CAS  PubMed  Google Scholar 

  4. Konsta M, Bournia VK, Dania V, Iliopoulos A (2014) Atrial fibrillation following intravenous zolendronic acid for osteoporosis. J Clin Rheumatol 20:239–240

    Article  PubMed  Google Scholar 

  5. Sharma A, Chatterjee S, Arbab-Zadeh A, Goyal S, Lichstein E, Ghosh J, et al. (2013) Risk of serious atrial fibrillation and stroke with use of biphosphonates. Chest 144:1311–1322

    Article  CAS  PubMed  Google Scholar 

  6. Sharma A, Einstein AJ, Vallakati A, Arbab-Zadeh A, Walker MD, Mukherjee D, et al. (2014) Risk of atrial fibrillation with use of oral and intravenous bisphosphonates. Am J Cardiol 113:1815–1821

    Article  CAS  PubMed  Google Scholar 

  7. Bonilla IM, Vargas-Pinto P, Nishijima Y, Pedraza-Toscano A, Ho HT, Long VP 3rd, et al. (2014) Ibandronate and ventricular arrhythmia risk. J Cardiovasc Electrophysiol 25:299–306

    Article  PubMed  Google Scholar 

  8. Ilgezdi ZD, Aktas I, Metin FD, Kepez A, Ozkan FU, Silte AD, et al. (2015) Acute effect of zoledronic acid infusion on atrial fibrillation development in patients with osteoporosis. Anatol J Cardiol 15:320–324

    Article  PubMed  Google Scholar 

  9. Howard PA, Barnes BJ, Vacek JL, Chen W, Lai SM (2010) Impact of biphosphonates on the risk of atrial fibrillation. Am J Cardiovasc Drugs 10:359–367

    Article  CAS  PubMed  Google Scholar 

  10. Aytemir K, Ozer N, Atalar E, Sade E, Aksoyek S, Ovunc K, et al. (2000) P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 23:1109–1112

    Article  CAS  PubMed  Google Scholar 

  11. Tisdale JE, Allen MR, Overholser BR, Jayner HA, Kovacs RJ (2015) Influence of zoledronic acid on atrial electrophysiological parameters and electrocardiographic measurements. J Cardiovasc Electrophysiol 26:671–677

    Article  PubMed  PubMed Central  Google Scholar 

  12. Antzelevitch C, Shimizu W, Yan GX, Sicouri S (1998) Cellular basis for QT dispersion. J Electrocardiol 30:168–175

    Article  PubMed  Google Scholar 

  13. Kors JA, Ritsema van Eck HJ, van Herpen G (2008) The meaning of the Tp-Te interval and its diagnostic value. J Electrocardiol 41:575–580

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Physical Therapy and Rehabilitation Clinic, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey

    I. Aktas, F. U. Ozkan, M. Y. Kaysin & P. Akpinar

  2. Family Medicine Clinic, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey

    C. Nazikoglu

  3. Cardiology Clinic, Marmara University Training and Research Hospital, Pendik, Istanbul, Turkey

    A. Kepez, Z. Dogan, C. Ileri, S. Saymaz & O. Erdogan

Authors
  1. I. Aktas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Nazikoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Kepez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. U. Ozkan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Y. Kaysin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Akpinar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Z. Dogan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. Ileri
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S. Saymaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. O. Erdogan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Kepez.

Ethics declarations

All subjects gave written informed consent and the institutional ethical committee approved the study protocol.

Conflicts of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aktas, I., Nazikoglu, C., Kepez, A. et al. Effect of intravenous zoledronic acid infusion on electrocardiographic parameters in patients with osteoporosis. Osteoporos Int 27, 3543–3547 (2016). https://doi.org/10.1007/s00198-016-3684-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-016-3684-6

Keywords

Search

Navigation